Industrial action is taking place at our hospitals from 7 - 13 April 2026
We'll contact you if your appointment needs to be rescheduled. If you haven't heard from us, please attend as planned.
A&E remains very busy - if your concern is less urgent, please use NHS 111 first.
✨ We’re bringing together patients, the public and clinicians for a community conversation about the future of health research across Cheshire & Merseyside.
Join us on 23 April at The Liner Hotel, Liverpool, for a day of shared stories, expert insights and co‑design sessions that put people at the heart of research.
🗓️ 23 April 2026
📍 Liverpool
⏰ 9:30am–3pm
Register via the QR code on the poster or follow the link in the comments.
#HealthResearch #NIHR #Liverpool #PublicInvolvement #ResearchForAll
We are proud to support #ThisisLiverpool a campaign from @lpoolcouncil celebrating the city’s diversity and reaffirming our collective stand against racism.
Find out more, unite against racism and share facts, not myths: https://t.co/gRz5VMTawB
Our therapies team were delighted to join one of their colleagues to celebrate #Eid today.
The team heard some personal insights about the importance of Eid and enjoyed learning, connecting and celebrating together.
It's National Moisture Associated Skin Damage Awareness day TODAY! If your organisation has participated, please share your photographs! @LHCHFT@medline#thinkMASD@harmfreecareuk
We asked staff to ''make a pledge'' to to help prevent and manage MASD.
Congratulations to @justinchiong_ , Cardiology Specialty Registrar who has been awarded a Clinical Research Training Fellowship by @TheBHF. This is the first time a fellowship of its kind has been awarded to a researcher at LHCH. https://t.co/eI3V7fKI26
It’s just over a week until national Moisture-Associated Skin Damage (MASD) Awareness Day on Thursday 19th March. Now in its fifth year, the day was created by the LHCH Tissue Viability team @TV_LHCH with @Medline. Visit https://t.co/Yz29pRgvRy to get involved. @harmfreecareuk
To coincide with IWD, marked earlier this week, we’d like you to meet Dr Archana Rao, Consultant Cardiologist specialising in devices and heart failure. You can read more about Archie and her inspirational career journey in our ‘Meet the Specialist’ series https://t.co/QXoh4wwhRv
Clinical outcomes of rate control versus rhythm control as the initial strategy in atrial fibrillation: insights from the GLORIA-AF registry #Afib@LHCHFT https://t.co/ZUA5j4k9KP
If something in your body doesn’t feel right, and you’re worried it could be cancer, contact your GP practice.
Know what's normal for you. Get to know your body and be aware of any new or concerning changes.
Read more about cancer symptoms ➡️ https://t.co/hivbfrsuIl
Long‐Term Follow‐Up After Atrioventricular Node Ablation in Patients With Atrial Fibrillation: A Nationwide Danish Cohort Study @LHCHFT@LivHPartners@DhirajGuptaBHRS https://t.co/8gtfkxPJqF
Non-antiarrhythmic pharmacotherapy in cardio-renal-metabolic disease and incident atrial fibrillation: a trial meta-analysis #Afib@LHCHFT@LivHPartners https://t.co/TqAZQCaZwh
Selecting the optimal method for assessment of #hypertension mediated organ damage: a personalised approach @LHCHFT@LivHPartners https://t.co/4EgeNGgEd9
Identification of #Biomarkers for Predicting New-Onset Atrial Fibrillation: A Systematic Review and Meta-Analysis @LHCHFT@LivHPartners@affirmo_eu https://t.co/Xc6IxUrUlz
Wonderful to see and hear that Lionel is doing so well after his care @lhchft earlier this year.
Very best wishes from all at LHCH for a happy and healthy 2026 💙
Risk of cancer following presentation with new-onset Atrial Fibrillation using data from UK National databases https://t.co/009Dmcz67x #Afib#cancer@LHCHFT@LivHPartners@affirmo_eu